Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | cytochrome P450 family protein | 0.0054 | 0.0032 | 0.0032 |
Echinococcus granulosus | glutamate receptor 2 | 0.0053 | 0.0021 | 0.0126 |
Mycobacterium leprae | Probable imidazole glycerol-phosphate dehydratase HisB | 0.0602 | 0.4712 | 0.5 |
Schistosoma mansoni | glutamate receptor AMPA | 0.0065 | 0.0121 | 0.0734 |
Brugia malayi | Glutamate receptor 2 precursor | 0.0065 | 0.0121 | 0.0124 |
Echinococcus multilocularis | Glutamate receptor, ionotropic kainate 2 | 0.0077 | 0.0226 | 0.1373 |
Brugia malayi | Cytochrome P450 family protein | 0.0054 | 0.0032 | 0.0032 |
Echinococcus granulosus | aldehyde dehydrogenase mitochondrial | 0.006 | 0.008 | 0.0488 |
Echinococcus granulosus | Glutamate receptor ionotropic kainate 2 | 0.0077 | 0.0226 | 0.1373 |
Echinococcus multilocularis | Glutamate receptor, ionotropic kainate 2 | 0.0077 | 0.0226 | 0.1373 |
Echinococcus multilocularis | glutamate (NMDA) receptor subunit | 0.0243 | 0.1647 | 1 |
Echinococcus granulosus | glutamate receptor ionotrophic AMPA 3 | 0.0077 | 0.0226 | 0.1373 |
Plasmodium vivax | phosphatase, putative | 0.0051 | 0 | 0.5 |
Schistosoma mansoni | glutamate receptor kainate | 0.0065 | 0.0121 | 0.0734 |
Echinococcus granulosus | glutamate receptor 2 | 0.0077 | 0.0226 | 0.1373 |
Loa Loa (eye worm) | glutamate receptor 2 | 0.0065 | 0.0121 | 0.0124 |
Brugia malayi | Glutamate receptor 1 precursor | 0.0065 | 0.0121 | 0.0124 |
Schistosoma mansoni | glutamate receptor NMDA | 0.0243 | 0.1647 | 1 |
Echinococcus multilocularis | Glutamate receptor, ionotropic kainate 2 | 0.0077 | 0.0226 | 0.1373 |
Plasmodium falciparum | bifunctional polynucleotide phosphatase/kinase | 0.0051 | 0 | 0.5 |
Plasmodium falciparum | phosphatase, putative | 0.0051 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0608 | 0.4768 | 0.4893 |
Plasmodium vivax | bifunctional polynucleotide phosphatase/kinase, putative | 0.0051 | 0 | 0.5 |
Schistosoma mansoni | glutamate receptor kainate | 0.0065 | 0.0121 | 0.0734 |
Loa Loa (eye worm) | glutamate receptor 1 | 0.0065 | 0.0121 | 0.0124 |
Schistosoma mansoni | aldehyde dehydrogenase | 0.006 | 0.008 | 0.0488 |
Echinococcus multilocularis | aldehyde dehydrogenase, mitochondrial | 0.006 | 0.008 | 0.0488 |
Echinococcus multilocularis | glutamate receptor 2 | 0.0053 | 0.0021 | 0.0126 |
Schistosoma mansoni | ATP-binding cassette transporter | 0.0065 | 0.0121 | 0.0734 |
Echinococcus multilocularis | glutamate receptor 2 | 0.0077 | 0.0226 | 0.1373 |
Schistosoma mansoni | glutamate receptor AMPA | 0.0065 | 0.0121 | 0.0734 |
Leishmania major | C-8 sterol isomerase-like protein | 0.119 | 0.9744 | 1 |
Echinococcus granulosus | Glutamate receptor ionotropic kainate 2 | 0.0077 | 0.0226 | 0.1373 |
Echinococcus granulosus | Glutamate receptor ionotropic kainate 2 | 0.0077 | 0.0226 | 0.1373 |
Echinococcus multilocularis | glutamate receptor, ionotrophic, AMPA 3 | 0.0077 | 0.0226 | 0.1373 |
Echinococcus granulosus | glutamate NMDA receptor subunit | 0.0243 | 0.1647 | 1 |
Toxoplasma gondii | aldehyde dehydrogenase | 0.006 | 0.008 | 0.5 |
Onchocerca volvulus | Bifunctional polynucleotide phosphatase\/kinase homolog | 0.0051 | 0 | 0.5 |
Schistosoma mansoni | glutamate receptor kainate | 0.0065 | 0.0121 | 0.0734 |
Mycobacterium ulcerans | imidazoleglycerol-phosphate dehydratase | 0.122 | 1 | 1 |
Trypanosoma cruzi | C-8 sterol isomerase, putative | 0.119 | 0.9744 | 1 |
Schistosoma mansoni | aldehyde dehydrogenase | 0.006 | 0.008 | 0.0488 |
Brugia malayi | ERG2 and Sigma1 receptor like protein | 0.119 | 0.9744 | 1 |
Schistosoma mansoni | glutamate receptor NMDA | 0.0077 | 0.0226 | 0.1373 |
Entamoeba histolytica | polynucleotide kinase-3-phosphatase, putative | 0.0051 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.119 | 0.9744 | 1 |
Trypanosoma brucei | C-8 sterol isomerase, putative | 0.119 | 0.9744 | 1 |
Echinococcus multilocularis | glutamate receptor 2 | 0.0065 | 0.0121 | 0.0734 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.